Lessons learnt from the medical and psychosocial evaluation of childhood acute lymphoblastic leukemia (ALL) survivors enrolled in EORTC Children Leukemia Group Trials between 1971 and 1998 and future perspectives for long-term outcome research

Piette, Caroline; de Rojas, Teresa; Suciu, Stefan; Kicinski, Michal; Bertrand, Yves; de Schaetzen, Gaetan; Gilotay, Caroline; Meulemans, Bart; Rossi, Séraphine; Röhrlich, Pierre; Benoit

doi:10.1016/j.jcpo.2018.02.006

Article (Scientific journals)

Lessons learnt from the medical and psychosocial evaluation of childhood acute lymphoblastic leukemia (ALL) survivors enrolled in EORTC Children Leukemia Group Trials between 1971 and 1998 and future perspectives for long-term outcome research

Piette, Caroline; de Rojas, Teresa; Suciu, Stefan et al.

2018 • In Journal of Cancer Policy, 15, p. 82-86

Permalink
https://hdl.handle.net/2268/224665

DOI
10.1016/j.jcpo.2018.02.006

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

JCP_Piette_2018.pdf

Publisher postprint (197.59 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Hematology
Pediatrics
Oncology

Author, co-author :

Piette, Caroline ; Université de Liège - ULiège > Département des sciences cliniques > Neuropédiatrie

de Rojas, Teresa

Suciu, Stefan

Kicinski, Michal

Bertrand, Yves

de Schaetzen, Gaetan

Gilotay, Caroline

Meulemans, Bart

Rossi, Séraphine

Röhrlich, Pierre

Benoit

Language :

English

Title :

Publication date :

12 February 2018

Journal title :

Journal of Cancer Policy

ISSN :

2213-5383

Publisher :

Elsevier, Netherlands

Volume :

Pages :

82-86

Available on ORBi :

since 08 June 2018

Statistics

Number of views

58 (2 by ULiège)

Number of downloads

157 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Duval, M., et al. Comparison of Escherichia coli–asparaginase withErwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children's Leukemia Group phase 3 trial. Blood 99 (2002), 2734–2739.
van der Werff Ten Bosch, J., et al. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund, U. K. 19 (2005), 721–726.
Millot, B.F., et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster – based protocol in increased- risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European organization for research and treatment. J. Clin. Oncol. 19 (2010), 1935–1942.
Vilmer, E., et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Leukemia 14 (2000), 2257–2266.
Van Der Kaaij, M.A.E., et al. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J. Clin. Oncol 30 (2012), 3854–3863.
Ware, J.J., Kosinski, M.M., Keller, S.S.D., A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 34 (1996), 220–233.
Zebrack, B.J., Landier, W., The perceived impact of cancer on quality of life for post-treatment survivors of childhood cancer. Qual. Life Res 20 (2011), 1595–1608.
Dupuis, G., Perrault, J., Lambany, M.-C., Kennedy, E., David, P., A new tool to assess quality of life: the Quality of Life Systemic Inventory. Qual. Life Cardiovasc. Care 5 (1998), 36–45.
Piette, C., et al. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials. Leukemia 32:Jan. (1) (2018), 244–248, 10.1038/leu.2017.289.
Piette, C., et al. Prophylactic CNS therapy (with or without radiation therapy) in medium-high risk acute lymphoblastic leukemia (ALL) children: long-term outcome evaluation of the randomized BFM-oriented trial 58832 (period 1983–1989) of the EORTC children leukemia group. Blood, 128, 2016.
Barbati, M., et al. Socioeconomic outcomes among long-Term childhood acute lymphoblastic leukemia survivors enrolled between 1971 and 1998 in the EORTC children leukemia group trials 58741, 58831/2 and 58881. Blood, 130, 2017.
De Rojas, T., et al. Fertility status among long-term childhood acute lymphoblastic leukemia survivors enrolled between 1971 and 1998 in the EORTC children leukemia group trials 58741, 58831/2 and 58881. Blood, 130, 2017.